As previously reported, Argus upgraded Herbalife (HLF) to Buy from Hold. The firm cites the company’s Q3 earnings beat reported earlier this month while also boosting its FY25 EPS view by 3c to $2.15 and its FY26 view by 4c to $2.64, the analyst tells investors in a research note. Argus adds however that while Herbalife’s reported revenue rose 270bps y/y, it was hurt by foreign currency headwinds.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLF: